Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2023-05-15
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question\[s\] it aims to answer are:
* What is the feasibility of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors.
* What is the acceptability of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors.
The secondary question\[s\] it aims to answer are:
\- What are the differences in depression, anxiety, serum cortisol, and quality of life between and within a companion dog walking intervention compared to an attention control education intervention for ICU survivors?
Participants in the intervention group will be asked to:
* Participate in dog walking with their pet dog at least three times per week, for at least 10 minutes each walk, for 8-weeks.
* Wear an activity monitor and record their dog walks in a diary.
* Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8.
* Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8.
Participants in the control group will be asked to:
* Read educational materials about their pet dog's health once every week (education materials are provided by the researchers).
* Wear an activity monitor and record when they read their education materials in a diary.
* Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8.
* Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8.
Participants will be assigned to an intervention group or a control group to see if there are differences in depression, anxiety, serum cortisol, and quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biobehavioral Effects of Therapy Dog Visitation in Elderly Intensive Care Unit Patients: A Pilot and Feasibility Study
NCT02997852
Effectiveness of an Educational Intervention of Spirituality in Nursing Professionals Working in Critical Health Care Settings to Promote Spiritual Self-care.
NCT07092657
ICU Experience in Family Members
NCT02940028
ICU Family Communication Study
NCT00720200
Relatives Visit Prior to Hospital Admission & Intensive Care Unit
NCT03605420
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
Companion dog walking
Companion Dog Walking
Participants will be asked to walk their dog three times per week, for a minimum of 30 minutes each day of walking, over an 8-week period.
Attention Control Group
Educational resources about dog health
Attention Control Group
Participants will be asked to read educational materials on dog health once per week, over an 8-week period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Companion Dog Walking
Participants will be asked to walk their dog three times per week, for a minimum of 30 minutes each day of walking, over an 8-week period.
Attention Control Group
Participants will be asked to read educational materials on dog health once per week, over an 8-week period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ICU survivors (spent ≥24 hours in the ICU)
* Will be discharged directly home from hospital.
* Able to speak, read, and understand English
* Physically capable of dog walking
* Individuals who have symptoms of depression and/or anxiety
* Individuals who own a companion dog and walk their dog \<10 minutes/week
* Participants scoring ≤ 20 seconds on the TUG Test
Exclusion Criteria
* Individuals with severe depression or anxiety
* Individuals who recently started treatment for depression and/or anxiety
* Individuals with cognitive impairment
* Dog walking is deemed unsafe with and for the dog
* Medical Provider authorization is indicated but not provided
* Individuals who live outside a 45-mile radius of Colorado Springs.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sigma Theta Tau International Honor Society of Nursing
OTHER
University of Missouri, Kansas City
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lindsey Nelson, MSN, RN
Role: PRINCIPAL_INVESTIGATOR
University of Missouri, Kansas City
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penrose Hospital
Colorado Springs, Colorado, United States
St. Francis Hospital
Colorado Springs, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2094468
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.